- Home
- NCRA vs PRTG Comparison
NCRA vs PRTG Comparison
Compare NCRA & PRTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCRA
- PRTG
- Stock Information
- Founded
- NCRA 2002
- PRTG 1973
- Country
- NCRA Taiwan
- PRTG British Virgin Islands
- Employees
- NCRA N/A
- PRTG N/A
- Industry
- NCRA Farming/Seeds/Milling
- PRTG Oil & Gas Production
- Sector
- NCRA Consumer Staples
- PRTG Energy
- Exchange
- NCRA Nasdaq
- PRTG Nasdaq
- Market Cap
- NCRA 14.4M
- PRTG 17.7M
- IPO Year
- NCRA N/A
- PRTG N/A
- Fundamental
- Price
- NCRA $1.01
- PRTG $5.89
- Analyst Decision
- NCRA
- PRTG
- Analyst Count
- NCRA 0
- PRTG 0
- Target Price
- NCRA N/A
- PRTG N/A
- AVG Volume (30 Days)
- NCRA 54.3K
- PRTG 237.7K
- Earning Date
- NCRA 08-13-2025
- PRTG 08-26-2025
- Dividend Yield
- NCRA N/A
- PRTG N/A
- EPS Growth
- NCRA N/A
- PRTG N/A
- EPS
- NCRA N/A
- PRTG N/A
- Revenue
- NCRA $16,647,379.00
- PRTG N/A
- Revenue This Year
- NCRA N/A
- PRTG N/A
- Revenue Next Year
- NCRA N/A
- PRTG N/A
- P/E Ratio
- NCRA N/A
- PRTG N/A
- Revenue Growth
- NCRA N/A
- PRTG N/A
- 52 Week Low
- NCRA $0.70
- PRTG $2.10
- 52 Week High
- NCRA $2.09
- PRTG $23.01
- Technical
- Relative Strength Index (RSI)
- NCRA 49.14
- PRTG 41.51
- Support Level
- NCRA $0.87
- PRTG $5.32
- Resistance Level
- NCRA $1.05
- PRTG $6.00
- Average True Range (ATR)
- NCRA 0.06
- PRTG 0.68
- MACD
- NCRA -0.00
- PRTG -0.01
- Stochastic Oscillator
- NCRA 77.78
- PRTG 22.33
About NCRA Nocera Inc.
Nocera Inc is engaged in the manufacturing of aquaculture equipment, construction of aquaculture facilities, managing and operating aquaculture facilities, and consulting for third-party operators of aquaculture facilities. Its primary business operations consist of the design, development, and production of RASs large-scale fish tank systems, for fish farms along with consulting, technology transfer, and aquaculture project management services to new and existing aquaculture management business services.
About PRTG Portage Biotech Inc.
Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through clinical proof of concept with an initial focus on unmet clinical needs. It is an immune-oncology company focused on overcoming immune resistance and currently managing 10 immuno-oncology assets at various development stages. Its pipeline products include IMM-60; IMM60 + Cell Therapy; (IMM60 / NY-ESO-1) + Keytruda and others.